{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:11:30Z","timestamp":1771920690900,"version":"3.50.1"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>This case report describes a 48-year-old woman with occult HPV-associated endocervical adenocarcinoma (Silva pattern B) presenting as bilateral ovarian metastases and pseudomyxoma peritonei\u2013like gelatinous ascites, despite normal cervical morphology and resolved HPV type 45 infection. Initial misdiagnosis as primary ovarian mucinous carcinoma was revised based on histopathology and immunohistochemistry (diffuse p16 positivity, ER-negative and PR-negative, Ki-67 index of 95%), confirming metastatic endocervical adenocarcinoma. The absence of appendiceal lesions excluded true PMP, attributing ascites to tumor mucin secretion. This case highlights the diagnostic challenges of occult cervical adenocarcinoma mimicking PMP and underscores the critical role of immunohistochemical profiling (p16, PAX8, WT1) to differentiate metastatic from primary ovarian tumors. The study emphasizes a multidisciplinary approach for accurate classification of mucinous neoplasms and raises awareness of rare metastatic pathways, such as transtubal dissemination, in HPV-associated cervical adenocarcinoma.<\/jats:p>","DOI":"10.3389\/fonc.2025.1630879","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:39:31Z","timestamp":1768372771000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: An incidentally discovered HPV-associated endocervical adenocarcinoma presenting as pseudomyxoma peritonei"],"prefix":"10.3389","volume":"15","author":[{"given":"Lijun","family":"Chen","sequence":"first","affiliation":[{"name":"Department of clinical medicine, Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, Affiliated Hospital Of Jining Medical University","place":["Jining, Shandong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1006\/gyno.2000.5826","article-title":"The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study","volume":"78","author":"Smith","year":"2000","journal-title":"Gynecol Oncol"},{"key":"B3","article-title":"Introduction of WHO classification of tumours of female reproductive organs, fourth edition","volume":"43","author":"Lu","year":"2014","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1111\/his.13977","article-title":"Revising the WHO classification: female genital tract tumours","volume":"76","author":"Cree","year":"2020","journal-title":"Histopathology"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70230-8","article-title":"Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study","volume":"11","author":"de Sanjose","year":"2010","journal-title":"Lancet Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.8.2613","article-title":"Human papillomavirus genotype as a major determinant of the course of cervical cancer","volume":"16","author":"Lombard","year":"1998","journal-title":"J Clin Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.21873\/invivo.13654","article-title":"Ovarian metastasis from human papillomavirus-associated usual-type endocervical adenocarcinoma: clinicopathological characteristics for distinguishing from primary ovarian mucinous or endometrioid tumor","volume":"38","author":"Cho","year":"2024","journal-title":"In Vivo"},{"key":"B8","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1186\/s13014-018-1197-5","article-title":"Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma of cervix after definitive radiotherapy or concurrent chemoradiotherapy","volume":"13","author":"Hu","year":"2018","journal-title":"Radiat Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.13683","article-title":"Tumor-specific expression of insulin-like growth factor II mRNA-binding protein 3 independently predicts worse survival of patients with adenocarcinoma of the ampulla of vater","volume":"39","author":"Kim","year":"2019","journal-title":"Anticancer Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2012.07.024","article-title":"Primary gallbladder carcinoma presenting as advanced-stage ovarian cancer","volume":"51","author":"Sun","year":"2012","journal-title":"Taiwan J Obstet Gynecol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ijgo.2014.04.018","article-title":"Prognostic factors of primary fallopian tube cancer in a single institute in Taiwan","volume":"127","author":"Horng","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/path.1480","article-title":"The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix","volume":"201","author":"Zielinski","year":"2003","journal-title":"J Pathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1186\/s12885-019-5582-8","article-title":"HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports","volume":"19","author":"Arfi","year":"2019","journal-title":"BMC Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/modpathol.3800510","article-title":"Immunohistochemistry for estrogen and progesterone receptors in the distinction of primary and metastatic mucinous tumors in the ovary: an analysis of 124 cases","volume":"19","author":"Vang","year":"2006","journal-title":"Mod Pathol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0000000000000251","article-title":"Calibration and optimization of p53, WT1, and napsin A immunohistochemistry ancillary tests for histotyping of ovarian carcinoma: canadian immunohistochemistry quality control (CIQC) experience","volume":"35","author":"Lee","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"B17","article-title":"The immunohistochemical expression of p53 and Ki67 in ovarian epithelial borderline tumors. Correlation with clinicopathological factors","volume":"53","author":"Giurgea","year":"2012","journal-title":"Rom J Morphol Embryol"},{"key":"B18","article-title":"Management of pseudomyxoma peritonei","author":"Fallis","year":"2015","journal-title":"J buon"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/0046-8177(95)90247-3","article-title":"Pseudomyxoma peritonei in women: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis, and relationship to ovarian mucinous tumors of low Malignant potential","volume":"26","author":"Ronnett","year":"1995","journal-title":"Hum Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3325\/cmj.2008.5.669","article-title":"Low grade peritoneal mucinous carcinomatosis associated with human papilloma virus infection: case report","volume":"49","author":"Gatalica","year":"2008","journal-title":"Croat Med J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"3066063","DOI":"10.1155\/2024\/3066063","article-title":"Pseudomyxoma peritonei in a case of carcinoma cervix: subtle finding with implications on management and prognosis","volume":"2024","author":"Kumari","year":"2024","journal-title":"Case Rep Oncol Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.10.004","article-title":"Ovarian metastasis in carcinoma of the uterine cervix","volume":"101","author":"Shimada","year":"2006","journal-title":"Gynecol Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2006.00854.x","article-title":"Ovarian metastases in early-stage cervical cancer (IA2-IIA): a multicenter retrospective study of 1965 patients (a Cooperative Task Force study)","volume":"17","author":"Landoni","year":"2007","journal-title":"Int J Gynecol Cancer"},{"key":"B24","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1097\/PGP.0b013e3181acefbf","article-title":"Endocervical adenocarcinoma in situ with ovarian metastases: a unique variant with potential for long-term survival","volume":"29","author":"Chang","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/01.pas.0000183569.71269.01","article-title":"Synchronous and metachronous endocervical and ovarian neoplasms: a different interpretation of HPV data","volume":"29","author":"Reichert","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/ijgc-2020-001257","article-title":"Revised 2018 International Federation of Gynecology and Obstetrics (FIGO) cervical cancer staging: A review of gaps and questions that remain","volume":"30","author":"Salvo","year":"2020","journal-title":"Int J Gynecol Cancer"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1630879\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T05:39:42Z","timestamp":1771911582000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1630879\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":26,"alternative-id":["10.3389\/fonc.2025.1630879"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1630879","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"article-number":"1630879"}}